{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:22:21Z","timestamp":1792801341168,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program of Guangdong Province","award":["2019B020227005"],"award-info":[{"award-number":["2019B020227005"]}]},{"name":"Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention","award":["2017B030314041"],"award-info":[{"award-number":["2017B030314041"]}]},{"name":"the Climbing Plan of Guangdong Provincial People\u2019s Hospital","award":["DFJH2020022"],"award-info":[{"award-number":["DFJH2020022"]}],"id":[{"id":"https:\/\/ror.org\/045kpgw45","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Clinical Research Center for Cardiovascular disease","award":["2020B1111170011"],"award-info":[{"award-number":["2020B1111170011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01671-4","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T03:57:50Z","timestamp":1736481470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of antihypertensive drug target genes with alzheimer\u2019s disease: a mendelian randomization study"],"prefix":"10.1186","volume":"17","author":[{"given":"He","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Worldwide trends in","year":"2021","unstructured":"Worldwide trends in. Hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"1671_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ajh.2009.212","volume":"23","author":"M Nagai","year":"2010","unstructured":"Nagai M, Hoshide S, Kario K. Hypertension and dementia. AM J HYPERTENS. 2010;23:116\u201324.","journal-title":"AM J HYPERTENS"},{"key":"1671_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/HYPERTENSIONAHA.114.03040","volume":"64","author":"C Iadecola","year":"2014","unstructured":"Iadecola C. Hypertension and dementia. Hypertension. 2014;64:3\u20135.","journal-title":"Hypertension"},{"key":"1671_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","volume":"322","author":"KA Walker","year":"2019","unstructured":"Walker KA, Sharrett AR, Wu A, Schneider A, Albert M, Lutsey PL, et al. Association of Midlife to late-life blood pressure patterns with Incident Dementia. JAMA-J AM MED ASSOC. 2019;322:535\u201345.","journal-title":"JAMA-J AM MED ASSOC"},{"key":"1671_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jamainternmed.2021.7009","volume":"182","author":"JW van Dalen","year":"2022","unstructured":"van Dalen JW, Brayne C, Crane PK, Fratiglioni L, Larson EB, Lobo A, et al. Association of systolic blood pressure with dementia risk and the role of Age, U-Shaped associations, and Mortality. JAMA INTERN MED. 2022;182:142\u201352.","journal-title":"JAMA INTERN MED"},{"key":"1671_CR6","doi-asserted-by":"publisher","first-page":"105515","DOI":"10.1016\/j.phrs.2021.105515","volume":"166","author":"L Scotti","year":"2021","unstructured":"Scotti L, Bassi L, Soranna D, Verde F, Silani V, Torsello A, et al. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: a meta-analysis. PHARMACOL RES. 2021;166:105515.","journal-title":"PHARMACOL RES"},{"key":"1671_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. NAT GENET. 2021;53:143\u20136.","journal-title":"NAT GENET"},{"key":"1671_CR8","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1002\/alz.13062","volume":"19","author":"M Nassan","year":"2023","unstructured":"Nassan M, Daghlas I, Piras IS, Rogalski E, Reus LM, Pijnenburg Y, et al. Evaluating the association between genetically proxied ACE inhibition and dementias. ALZHEIMERS DEMENT. 2023;19:3894\u2013901.","journal-title":"ALZHEIMERS DEMENT"},{"key":"1671_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13195-021-00782-y","volume":"13","author":"YN Ou","year":"2021","unstructured":"Ou YN, Yang YX, Shen XN, Ma YH, Chen SD, Dong Q, et al. Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer\u2019s disease: a mendelian randomization study. ALZHEIMERS RES THER. 2021;13:41.","journal-title":"ALZHEIMERS RES THER"},{"key":"1671_CR10","unstructured":"Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, Muiesan ML et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. EUR J INTERN MED. 2024."},{"key":"1671_CR11","first-page":"109","volume":"37","author":"BD Umans","year":"2021","unstructured":"Umans BD, Battle A, Gilad Y. Where Are Disease-Associated eQTLs? TRENDS GENET. 2021;37:109\u201324.","journal-title":"Where Are Disease-Associated eQTLs? TRENDS GENET"},{"key":"1671_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. NAT GENET. 2021;53:1300\u201310.","journal-title":"NAT GENET"},{"key":"1671_CR13","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx","year":"2020","unstructured":"The GTEx. Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"1671_CR14","unstructured":"Wang D, Liu S, Warrell J, Won H, Shi X, Navarro F et al. Comprehensive functional genomic resource and integrative model for the human brain. Science. 2018;362."},{"key":"1671_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41588-022-01154-4","volume":"54","author":"T Qi","year":"2022","unstructured":"Qi T, Wu Y, Fang H, Zhang F, Liu S, Zeng J, et al. Genetic control of RNA splicing and its distinct role in complex trait variation. NAT GENET. 2022;54:1355\u201363.","journal-title":"NAT GENET"},{"key":"1671_CR16","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","volume":"375","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf B, Davies NM, Swanson SA, VanderWeele TJ, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ-BRIT MED J. 2021;375:n2233.","journal-title":"BMJ-BRIT MED J"},{"key":"1671_CR17","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. NUCLEIC ACIDS RES. 2006;34:D668\u201372.","journal-title":"NUCLEIC ACIDS RES"},{"key":"1671_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. NAT GENET. 2018;50:1412\u201325.","journal-title":"NAT GENET"},{"key":"1671_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. NAT GENET. 2022;54:412\u201336.","journal-title":"NAT GENET"},{"key":"1671_CR20","unstructured":"FinnGen. FinnGen documentation of R9 release. https:\/\/finngen.gitbook.io\/documentation\/. 2023."},{"key":"1671_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"1671_CR22","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/ije\/dyz155","volume":"49","author":"VM Walker","year":"2020","unstructured":"Walker VM, Kehoe PG, Martin RM, Davies NM. Repurposing antihypertensive drugs for the prevention of Alzheimer\u2019s disease: a mendelian randomization study. INT J EPIDEMIOL. 2020;49:1132\u201340.","journal-title":"INT J EPIDEMIOL"},{"key":"1671_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-022-00963-3","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Hu Y, Zhang Y, Zhang H, Gao S, Wang L, et al. Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer\u2019s disease GWAS and self-report proxy phenotype GWAX. ALZHEIMERS RES THER. 2022;14:17.","journal-title":"ALZHEIMERS RES THER"},{"key":"1671_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3233\/JAD-180282","volume":"64","author":"NP Rocha","year":"2018","unstructured":"Rocha NP, Toledo A, Corgosinho L, de Souza LC, Guimaraes HC, Resende E, et al. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-beta42 Burden in Alzheimer\u2019s Disease. J ALZHEIMERS DIS. 2018;64:1085\u201390.","journal-title":"J ALZHEIMERS DIS"},{"key":"1671_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.biopsych.2022.11.002","volume":"93","author":"YJ Ge","year":"2023","unstructured":"Ge YJ, Ou YN, Deng YT, Wu BS, Yang L, Zhang YR, et al. Prioritization of drug targets for neurodegenerative diseases by integrating genetic and proteomic data from brain and blood. BIOL PSYCHIAT. 2023;93:770\u20139.","journal-title":"BIOL PSYCHIAT"},{"key":"1671_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1192\/bjpo.bp.116.004184","volume":"3","author":"K Fazal","year":"2017","unstructured":"Fazal K, Perera G, Khondoker M, Howard R, Stewart R. Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer\u2019s disease. BJPSYCH OPEN. 2017;3:158\u201364.","journal-title":"BJPSYCH OPEN"},{"key":"1671_CR27","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1523\/JNEUROSCI.1549-07.2007","volume":"27","author":"K Zou","year":"2007","unstructured":"Zou K, Yamaguchi H, Akatsu H, Sakamoto T, Ko M, Mizoguchi K, et al. Angiotensin-converting enzyme converts amyloid beta-protein 1\u201342 (abeta(1\u201342)) to Abeta(1\u201340), and its inhibition enhances brain abeta deposition. J NEUROSCI. 2007;27:8628\u201335.","journal-title":"J NEUROSCI"},{"key":"1671_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2017.00082","volume":"8","author":"K Asraf","year":"2017","unstructured":"Asraf K, Torika N, Danon A, Fleisher-Berkovich S. Involvement of the bradykinin B(1) receptor in Microglial activation: in Vitro and in vivo studies. FRONT ENDOCRINOL. 2017;8:82.","journal-title":"FRONT ENDOCRINOL"},{"key":"1671_CR29","doi-asserted-by":"publisher","first-page":"104833","DOI":"10.1016\/j.nbd.2020.104833","volume":"139","author":"PK Singh","year":"2020","unstructured":"Singh PK, Chen ZL, Ghosh D, Strickland S, Norris EH. Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer\u2019s patients. NEUROBIOL DIS. 2020;139:104833.","journal-title":"NEUROBIOL DIS"},{"key":"1671_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Orchard SG, Nelson MR, Fravel MA, Ernst ME. Angiotensin receptor blockers and cognition: a scoping review. CURR HYPERTENS REP. 2024;26:1\u201319.","journal-title":"CURR HYPERTENS REP"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01671-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01671-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:08:02Z","timestamp":1757131682000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01671-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01671-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article was revised: changes include adjusting the author affiliation order and funding information to reflect updated institutional details. The primary affiliation is now: \u201cGuangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Cardiovascular Institute, Guangdong Provincial People\u2019s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China\u201d. The secondary affiliation is \u201cSchool of Medicine, South China University of Technology, Guangzhou, China\u201d. Funding statement was updated to: This work was supported by the Noncommunicable Chronic Diseases\u2010National Science and Technology Major Project of China (No. 2023ZD0508906 and No. 2024ZD0526803), The Climbing Plan of Guangdong Provincial People\u2019s Hospital (DFJH2020022), and Guangdong Special Funds for Science and Technology Innovation Strategy (Stability support for scientific research institutions affiliated to Guangdong Province\u2010GDCI 2024).","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors listed have read and approved the submission of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}